USP5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.069000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.796600E-01
Normal-vs-Stage2
3.181000E-01
Normal-vs-Stage3
6.768800E-01
Normal-vs-Stage4
9.800200E-01
Stage1-vs-Stage2
8.392000E-01
Stage1-vs-Stage3
6.736600E-01
Stage1-vs-Stage4
9.916400E-01
Stage2-vs-Stage3
4.939600E-01
Stage2-vs-Stage4
8.597400E-01
Stage3-vs-Stage4
6.798000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.346200E-02
Normal-vs-AfricanAmerican
5.405400E-01
Normal-vs-Asian
4.744800E-01
Caucasian-vs-AfricanAmerican
6.958200E-01
Caucasian-vs-Asian
3.368600E-01
AfricanAmerican-vs-Asian
3.668800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.490240E-01
Normal-vs-Female
3.199000E-01
Male-vs-Female
6.100600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.919200E-01
Normal-vs-Age(41-60Yrs)
3.811800E-02
Normal-vs-Age(61-80Yrs)
6.474800E-01
Normal-vs-Age(81-100Yrs)
1.945780E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.412200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.728200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.684600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.965380E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.095200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.092200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.285800E-01
Normal-vs-Daily Drinker
5.882000E-02
Normal-vs-Weekly Drinker
9.514400E-01
Normal-vs-Occasional Drinker
1.865900E-02
Normal-vs-Social Drinker
3.313600E-01
Non Drinker-vs-Daily Drinker
2.647800E-01
Non Drinker-vs-Weekly Drinker
7.458000E-01
Non Drinker-vs-Occasional Drinker
2.141000E-01
Non Drinker-vs-Social Drinker
5.952200E-01
Daily Drinker-vs-Weekly Drinker
2.852400E-01
Daily Drinker-vs-Occasional Drinker
2.798400E-03
Daily Drinker-vs-Social Drinker
1.194790E-01
Weekly Drinker-vs-Occasional Drinker
5.871600E-02
Weekly Drinker-vs-Social Drinker
3.730200E-01
Occasional Drinker-vs-Social Drinker
5.249200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.742600E-01
Normal-vs-Grade 2
2.390200E-01
Normal-vs-Grade 3
1.541800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.144230E-01
Grade 1-vs-Grade 3
5.715000E-01
Grade 1-vs-Grade 4
2.742600E-01
Grade 2-vs-Grade 3
8.158000E-02
Grade 2-vs-Grade 4
2.390200E-01
Grade 3-vs-Grade 4
1.541800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.568000E-01
Normal-vs-NonDiabetic
1.612150E-01
Diabetic-vs-NonDiabetic
8.655800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.791000E-01
Normal-vs-NoPancreatitis
3.156400E-01
Pancreatitis-vs-NoPancreatitis
3.709400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.568590E-01
Normal-vs-N1
5.053400E-01
N0-vs-N1
3.011200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.134590E-01
Normal-vs-TP53-NonMutant
1.480440E-01
TP53-Mutant-vs-TP53-NonMutant
9.819800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
